{
  "url": "https://openlegislation.uk/eu-regulation-2006-1729/annex/division-A/division-2/division-2.1/division-2.1.3",
  "json_url": "https://openlegislation.uk/eu-regulation-2006-1729/annex/division-A/division-2/division-2.1/division-2.1.3.json",
  "legislation": "eur/2006/1729",
  "legislation_title": "Commission Regulation (EC) No 1729/2006 of 23 November 2006 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards firocoxib and triclabendazole (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2006-1729",
  "path": "annex/division/A/division/2/division/2.1/division/2.1.3",
  "kind": "division",
  "number": "2.1.3",
  "heading": "Benzimidazoles and pro-benzimidazoles",
  "text": "Not for use in animals producing milk for human consumption.’\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\n‘Triclabendazole\nSum of extractable residues that may be oxidised to ketotriclabendazole\nAll ruminants\n225 μg/kg\nMuscle\n100 μg/kg\nFat\n250 μg/kg\nLiver\n150 μg/kg\nKidney",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Not for use in animals producing milk for human consumption.’"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2006/1729/annex/division/A/division/2/division/2.1/division/2.1.3",
    "retrieved_at": "2026-11-01T14:53:20.262429+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}